Search results
Results from the WOW.Com Content Network
On Thursday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported third-quarter adjusted EPS of $12.46, up 8% year-over-year, beating the consensus of $11.69. The company reported sales of $3.72 ...
On Friday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending ...
Regeneron stock surges on positive results in eye disease drug trial. September 8, 2022 at 12:57 PM ...
Key highlights of the past week include litigation updates, acquisitions, and other regulatory and pipeline updates. Biotech Stock Roundup: REGN Wins Against AMGN, VRTX to Acquire Semma & More ...
Would a stock split help lead Regeneron Pharmaceuticals shares higher?
Regeneron (REGN) closed at $615.88 in the latest trading session, marking a -0.8% move from the prior day. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 ...
Regeneron (REGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Regeneron stock opened up nearly 6 points Thursday morning. For premium support please call: 800-290-4726 more ways to reach us